This table presents recent patent oppositions filed by Ascendis Pharma Growth Disorders A/s against its competitors. It outlines key details of each case, including the patent title, filing date and the applicant. This information provides insights into the competitive landscape and highlights active disputes over patent grant within the industry.

Patent NumberTitleApplicantOpposition Date
EP3175863Variants Of C-Type Natriuretic PeptideBIOMARIN PHARMACEUTICAL INC.Sep 1, 2022